BioLife Solutions (BLFS)
(Delayed Data from NSDQ)
$23.98 USD
-0.81 (-3.27%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $23.99 +0.01 (0.04%) 7:00 PM ET
2-Buy of 5 2
F Value A Growth C Momentum B VGM
Cash flow Statements
Fiscal Year End for BioLife Solutions, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -66.43 | -139.81 | -7.64 | 2.67 | -1.66 |
Depreciation/Amortization & Depletion | 12.31 | 16.49 | 12.99 | 5.07 | 1.80 |
Net Change from Assets/Liabilities | 1.47 | -14.91 | -3.53 | -1.78 | -4.47 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 40.15 | 129.73 | -6.41 | 0.69 | 5.55 |
Net Cash From Operating Activities | -12.50 | -8.49 | -4.59 | 6.65 | 1.21 |
Property & Equipment | -6.38 | -10.39 | -8.38 | -1.93 | -0.68 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 1.56 | -14.95 | -11.19 |
Investments | 29.07 | -44.20 | 0.00 | -2.00 | -2.50 |
Other Investing Activities | -4.86 | -3.54 | -6.37 | -5.85 | -12.66 |
Net Cash from Investing Activities | 17.84 | -58.12 | -13.19 | -24.72 | -27.02 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 10.75 | 0.32 | 1.42 | 101.59 | 1.18 |
Issuance (Repayment) of Debt | -0.50 | 17.84 | 1.34 | 0.98 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | -4.23 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.34 | -1.84 | -1.30 | -0.50 | 0.42 |
Net Cash from Financing Activities | 10.59 | 16.32 | -2.78 | 102.08 | 1.60 |
Effect of Exchange Rate Changes | 0.04 | -0.11 | -0.02 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 15.97 | -50.40 | -20.59 | 84.01 | -24.21 |
Cash at Beginning of Period | 19.47 | 69.87 | 90.46 | 6.45 | 30.66 |
Cash at End of Period | 35.44 | 19.47 | 69.87 | 90.46 | 6.45 |
Diluted Net EPS | -1.52 | -3.29 | -0.20 | -0.03 | -0.09 |
Fiscal Year End for BioLife Solutions, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -30.94 | -10.22 | -66.43 | -53.05 | -23.91 |
Depreciation/Amortization & Depletion | 4.64 | 2.28 | 12.31 | 9.92 | 6.65 |
Net Change from Assets/Liabilities | 0.59 | -2.64 | 1.47 | -3.77 | -1.87 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 27.69 | 6.11 | 40.15 | 32.08 | 8.71 |
Net Cash From Operating Activities | 1.98 | -4.48 | -12.50 | -14.81 | -10.43 |
Property & Equipment | -1.35 | -0.36 | -6.38 | -5.40 | -3.90 |
Acquisition/ Disposition of Subsidiaries | -13.04 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 2.33 | 0.60 | 29.07 | 22.73 | 18.67 |
Other Investing Activities | -1.59 | -0.46 | -4.86 | -3.45 | -2.55 |
Net Cash from Investing Activities | -13.66 | -0.22 | 17.84 | 13.88 | 12.22 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.09 | 0.00 | 10.75 | 0.37 | 0.31 |
Issuance (Repayment) of Debt | -0.47 | -0.24 | -0.50 | -0.68 | -0.26 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -1.28 | -0.71 | 0.34 | 1.06 | 0.09 |
Net Cash from Financing Activities | -1.66 | -0.95 | 10.59 | 0.75 | 0.14 |
Effect of Exchange Rate Changes | -0.07 | -0.07 | 0.04 | -0.03 | 0.03 |
Net Change In Cash & Equivalents | -13.39 | -5.71 | 15.97 | -0.21 | 1.96 |
Cash at Beginning of Period | 35.44 | 35.44 | 19.47 | 19.47 | 19.47 |
Cash at End of Period | 22.05 | 29.73 | 35.44 | 19.27 | 21.43 |
Diluted Net EPS | -0.45 | -0.22 | -0.30 | -0.67 | -0.23 |